Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?
Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?
Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?
Submitted by
admin
on November 7, 2017 - 10:56am
Source:
Fierce Pharma
News Tags:
Allergan
Kythera
Kybella
Headline:
Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?
Do Not Allow Advertisers to Use My Personal information
